CAPR - Capricor Therapeutics Inc. (CAPR) CEO Linda Marban on Q1 2022 Results - Earnings Call Transcript
Capricor Therapeutics, Inc. (CAPR) Q1 2022 Earnings Conference Call May 10, 2022, 16:30 ET Company Participants Anthony Bergmann - CFO & Corporate Treasurer Linda Marban - Co-Founder, President, CEO & Director Conference Call Participants Joseph Pantginis - H.C. Wainwright & Co. Presentation Operator Good day, ladies and gentlemen, and welcome to the Capricor Therapeutics, Inc. First Quarter 2022 Financial Earnings Call. [Operator Instructions]. At this time, I would like to turn the call over to Mr. Bergmann, Capricor Therapeutics' Chief Financial Officer. Please go ahead, sir. Anthony Bergmann Thank you. Thank you for joining today's call. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates, our future research and development plans, including our anticipated conduct and timing of preclinical and clinical
For further details see:
Capricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q1 2022 Results - Earnings Call Transcript